Marinus Pharmaceuticals
MRNS
$1.40
Share price
-1.06%
Change (1 day)
-83.03%
Change (1 year)
Categories
Earnings for Marinus Pharmaceuticals (MRNS)
Earnings in 2023 (TTM): -$0.15 B
According to Marinus Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -$0.15 B. In 2022 the company made an earning of -$16.43 M an increase over its 2021 earnings that were of -$98.78 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Marinus Pharmaceuticals from 2013 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | -$0.15 B | 770.17% |
| 2022 | -$16.43 M | -83.37% |
| 2021 | -$98.78 M | 46.39% |
| 2020 | -$67.48 M | 24.67% |
| 2019 | -$54.13 M | 47.37% |
| 2018 | -$36.73 M | 94.33% |
| 2017 | -$18.9 M | -34.02% |
| 2016 | -$28.65 M | 15.24% |
| 2015 | -$24.86 M | 129.47% |
| 2014 | -$10.84 M | 105.55% |
| 2013 | -$5.27 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Supernus Pharmaceuticals
SUPN | $5.18 M | -103.63% | 🇺🇸 USA |
 Endo International
ENDPQ | -$2.4 B | 1,573.34% | 🇮🇪 Ireland |
 AcelRx Pharmaceuticals
ACRX | -$10.29 M | -92.80% | 🇺🇸 USA |
 Eagle Pharmaceuticals
EGRX | $35.65 M | -124.95% | 🇺🇸 USA |